Education
About Us
Working with TipRanks
Follow Us
PureTech Health PLC (GB:PRTC)
LSE:PRTC
Total Valuation
PureTech Health has a market cap or net worth of £318.49M. The enterprise value is 314.79M.
Market Cap£318.49M
Enterprise Value314.79M
Share Statistics
PureTech Health has 240,189,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding240,189,450
Owned by Insiders3.43%
Owned by Institutions0.11%
Financial Efficiency
PureTech Health’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -41.53%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-41.53%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee8.33K
Profits Per Employee-740.31K
Employee Count90
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PureTech Health is -10.30. PureTech Health’s PEG ratio is -0.12.
PE Ratio-10.30
PS Ratio533.91
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-6.37
Price to Operating Cash Flow-6.39
PEG Ratio-0.12
Income Statement
In the last 12 months, PureTech Health had revenue of 750.00K and earned -65.70M in profits. Earnings per share was -0.24.
Revenue750.00K
Gross Profit-95.48M
Operating Income-146.20M
Pretax Income-36.10M
Net Income-65.70M
EBITDA-17.68M
Earnings Per Share (EPS)-0.24
Cash Flow
In the last 12 months, operating cash flow was -120.80M and capital expenditures 0.00, giving a free cash flow of -120.80M billion.
Operating Cash Flow-120.80M
Free Cash Flow-120.80M
Free Cash Flow per Share-0.50
Dividends & Yields
PureTech Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.79
52-Week Price Change-39.86%
50-Day Moving Average133.88
200-Day Moving Average151.58
Relative Strength Index (RSI)49.60
Average Volume (3m)886.72K
Important Dates
PureTech Health upcoming earnings date is Apr 30, 2025, TBA Not Confirmed.
Last Earnings DateAug 28, 2024
Next Earnings DateApr 30, 2025
Ex-Dividend Date―
Financial Position
PureTech Health as a current ratio of 6.76, with Debt / Equity ratio of 45.82%
Current Ratio6.76
Quick Ratio6.76
Debt to Market Cap<0.01
Net Debt to EBITDA9.37
Interest Coverage Ratio-10.84
Taxes
In the past 12 months, PureTech Health has paid 30.52M in taxes.
Income Tax30.52M
Effective Tax Rate-0.85
Enterprise Valuation
PureTech Health EV to EBITDA ratio is -28.90, with an EV/FCF ratio of -4.81.
EV to Sales681.32
EV to EBITDA-28.90
EV to Free Cash Flow-4.81
EV to Operating Cash Flow-4.82
Balance Sheet
PureTech Health has £500.42M in cash and marketable securities with $4.26M in debt, giving a net cash position of -£355.68M billion.
Cash & Marketable Securities£500.42M
Total Debt$4.26M
Net Cash-£355.68M
Net Cash Per Share-£1.48
Tangible Book Value Per Share£1.67
Margins
Gross margin is -17425.00%, with operating margin of -19493.20%, and net profit margin of -8759.60%.
Gross Margin-17425.00%
Operating Margin-19493.20%
Pretax Margin-4813.73%
Net Profit Margin-8759.60%
EBITDA Margin-2357.47%
EBIT Margin-3015.33%
Analyst Forecast
The average price target for PureTech Health is £455.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£455.00
Price Target Upside266.94% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―